These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 2749014)
1. [Three cases of Torsades de pointes]. Nanimatsu H; Shibayama H; Koumatsu A; Inoue T; Maeda T; Saikawa T; Ito S; Takaki R; Tsunematsu Y Kokyu To Junkan; 1989 May; 37(5):535-9. PubMed ID: 2749014 [TBL] [Abstract][Full Text] [Related]
2. [Torsade de Pointes with T wave alternans in a patient receiving moderate dose of chlorpromazine: report of a case]. Ochiai H; Kashiwagi M; Usui T; Oyama Y; Tokita Y; Ishikawa T Kokyu To Junkan; 1990 Aug; 38(8):819-22. PubMed ID: 2218093 [TBL] [Abstract][Full Text] [Related]
3. The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias. Topilski I; Rogowski O; Rosso R; Justo D; Copperman Y; Glikson M; Belhassen B; Hochenberg M; Viskin S J Am Coll Cardiol; 2007 Jan; 49(3):320-8. PubMed ID: 17239713 [TBL] [Abstract][Full Text] [Related]
4. Torsades de pointes due to drug interaction between disopyramide and clarithromycin. Choudhury L; Grais IM; Passman RS Heart Dis; 1999; 1(4):206-7. PubMed ID: 11720625 [TBL] [Abstract][Full Text] [Related]
5. [Torsades de pointes initiated by slow ventricular stimulation]. Fontaine G; Frank R; Lascault G; Tonet JL; Fillette F; Grosgogeat Y Arch Mal Coeur Vaiss; 1983 Aug; 76(8):918-24. PubMed ID: 6414425 [TBL] [Abstract][Full Text] [Related]
6. Takotsubo cardiomyopathy and QT interval prolongation: who are the patients at risk for torsades de pointes? Samuelov-Kinori L; Kinori M; Kogan Y; Swartzon M; Shalev H; Guy D; Ferenidou F; Mashav N; Sadeh B; Atzmony L; Kliuk-Ben-Basat O; Steinvil A; Justo D J Electrocardiol; 2009; 42(4):353-357.e1. PubMed ID: 19261294 [TBL] [Abstract][Full Text] [Related]
7. [Sotalol and torsades de pointes ventricular tachycardia]. Petersen HH; Sandøe E Ugeskr Laeger; 1996 May; 158(19):2711-6. PubMed ID: 8744073 [TBL] [Abstract][Full Text] [Related]
8. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872. Bril A; Gout B; Bonhomme M; Landais L; Faivre JF; Linee P; Poyser RH; Ruffolo RR J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331 [TBL] [Abstract][Full Text] [Related]
9. Torsades de pointes associated with acquired long QT syndrome: observation of 7 cases. Takahashi N; Ito M; Inoue T; Koumatsu K; Takeshita Y; Tsumabuki S; Tamura M; Inoue K; Maeda T; Saikawa T J Cardiol; 1993; 23(1):99-106. PubMed ID: 8164140 [TBL] [Abstract][Full Text] [Related]
10. [Torsades de pointes ventricular tachycardia induced by disopyramide at therapeutic serum concentration]. Aarskog D; Reikvam A Tidsskr Nor Laegeforen; 1992 Aug; 112(19):2511-3. PubMed ID: 1412257 [TBL] [Abstract][Full Text] [Related]
11. A case series of drug-induced long QT syndrome and Torsade de Pointes. Tong KL; Lau YS; Teo WS Singapore Med J; 2001 Dec; 42(12):566-70. PubMed ID: 11989578 [TBL] [Abstract][Full Text] [Related]
12. [Torsades de Pointes: a cause of syncope in sinus node dysfunction]. Velázquez Rodríguez E; Rangel Rojo J; Ortega Sánchez A; Zamudio Villafuerte A; González Gallardo S Arch Inst Cardiol Mex; 1998; 68(6):498-505. PubMed ID: 10365226 [TBL] [Abstract][Full Text] [Related]
13. [Erythrocyte-induced "torsade de pointes" ventricular tachycardia]. Lengyel C; Várkonyi T; Fazekas T Orv Hetil; 1997 Apr; 138(16):1003-6. PubMed ID: 9153994 [TBL] [Abstract][Full Text] [Related]
14. [Dangerous arrhythmias]. Gertsch M; Fuhrer J Schweiz Med Wochenschr; 1993 May; 123(17):833-43. PubMed ID: 8497770 [TBL] [Abstract][Full Text] [Related]
15. Verapamil prevents torsade de pointes by reduction of transmural dispersion of repolarization and suppression of early afterdepolarizations in an intact heart model of LQT3. Milberg P; Reinsch N; Osada N; Wasmer K; Mönnig G; Stypmann J; Breithardt G; Haverkamp W; Eckardt L Basic Res Cardiol; 2005 Jul; 100(4):365-71. PubMed ID: 15944809 [TBL] [Abstract][Full Text] [Related]
16. ['Cardiac ballet' with and without amiodarone]. Balestra B; Hess T Schweiz Med Wochenschr; 1993 Jan; 123(1-2):20-5. PubMed ID: 8421775 [TBL] [Abstract][Full Text] [Related]
17. Giant T-U waves precede torsades de pointes in long QT syndrome: a systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation. Kirchhof P; Franz MR; Bardai A; Wilde AM J Am Coll Cardiol; 2009 Jul; 54(2):143-9. PubMed ID: 19573731 [TBL] [Abstract][Full Text] [Related]
18. QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system. Pearson EC; Woosley RL Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):747-53. PubMed ID: 15918160 [TBL] [Abstract][Full Text] [Related]
19. Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de Pointes. Abi-Gerges N; Philp K; Pollard C; Wakefield I; Hammond TG; Valentin JP Fundam Clin Pharmacol; 2004 Apr; 18(2):139-51. PubMed ID: 15066127 [TBL] [Abstract][Full Text] [Related]
20. [A case of cardiac arrest after torsades de pointes due to prolonged QT interval syndrome possibly associated with subarachnoid hemorrhage]. Yamaguchi S; Watanabe K; Mishio M; Okuda Y; Kitajima T Masui; 1999 Jun; 48(6):644-6. PubMed ID: 10402818 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]